Behrouz Nezafat Maldonado
Datos Biográficos
| ID | 9803374 |
|---|---|
| NOMBRE | Behrouz Nezafat Maldonado |
| NOMBRES | Behrouz Nezafat |
| APELLIDO | Maldonado |
| FIRMA | MALDONADO B N |
| AFILIACIONES | Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, UK |
| VERIFICADO | No |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 1 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2020 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2020 |
| ÍNDICE H | 0 |
What does ‘leave no one behind’ mean for humanitarian crises-affected populations in the Covid-19 pandemic
Background Risks of hospitalized infections associated with newer biologic agents have not been well characterized in relation to risks with anti-TNF therapy, especially in rheumatoid arthritis (RA) patients with high comorbidity burdens. Objectives To compare the risk of hospitalized infections among RA patients switching from anti-TNF therapy to rituximab (RTX), abatacept (ABA) or another anti-TNF. Methods Using data from 2002-10 from the U.S. …
Sin obras prominentes en esta página.
What does ‘leave no one behind’ mean for humanitarian crises-affected populations in the Covid-19 pandemic
Background Risks of hospitalized infections associated with newer biologic agents have not been well characterized in relation to risks with anti-TNF therapy, especially in rheumatoid arthritis (RA) patients with high comorbidity burdens. Objectives To compare the risk of hospitalized infections among RA patients switching from anti-TNF therapy to rituximab (RTX), abatacept (ABA) or another anti-TNF. Methods Using data from 2002-10 from the U.S. …
Abatacept (1 obras) · Cancer (1 obras) · Comorbidity (1 obras) · Confidence interval (1 obras) · Confounding (1 obras) · COVID-19 Clinical Research Studies (1 obras) · Hazard ratio (1 obras) · Internal Medicine (1 obras) · Lymphoma (1 obras) · Medicine (1 obras)